Evidence map›Paper›PMID 32322683›Full record

ArticleTransgender health2020

An Observational Study of Hypertension and Thromboembolism Among Transgender Patients Using Gender-Affirming Hormone Therapy.

Maria Pyra, Isabel Casimiro, Laura Rusie, Nat Ross, Cori Blum, Kristin Keglovitz Baker, Andie Baker, John Schneider

Open access · hybridAbstract read
In one paragraph

Article in Transgender health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Gender-affirming hormone therapy in the transgender patient: influence on thrombotic risk.Hematology. American Society of Hematology. Education Program · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Hypertension in transgender individuals.Journal of human hypertension · 2023
    Review
  11. Article
  12. Gender-affirming hormonal therapy for transgender and gender-diverse people-A narrative review.Best practice & research. Clinical obstetrics & gynaecology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria PyraHoward Brown Health Center, Chicago, Illinois.
Isabel CasimiroSection of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, University of Chicago Medicine, Chicago, Illinois.
Laura RusieHoward Brown Health Center, Chicago, Illinois.
Nat RossHoward Brown Health Center, Chicago, Illinois.
Cori BlumHoward Brown Health Center, Chicago, Illinois.
Kristin Keglovitz BakerHoward Brown Health Center, Chicago, Illinois.
Andie BakerHoward Brown Health Center, Chicago, Illinois.
John SchneiderHoward Brown Health Center, Chicago, Illinois.
Howard Brown Health Center · USUniversity of Chicago · US

Funding

INTERGRATED CLINICAL AND BASIC ENDOCRINOLOGY RESEARCHT32DK007011 · NIDDK · UNIVERSITY OF CHICAGO · PI Raghavendra G Mirmira · 1986 to 2026
$5.8M
NIDDK NIH HHS T32 DK007011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

hypertensionsex hormonesthromboembolism

Identifiers

PMID32322683
PMCPMC7173689
OpenAlexW3011391921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.